Medtronic (NYSE:MDT) said today that it launched its MyCareLink Heart mobile application intended to connect users’ smartphone devices directly to the company’s portfolio of connected pacemakers, touting it as the first such mobile application of its kind. The newly launched application is compatible with all of the Fridley, Minn.-based medical giant’s BlueSync technology-enabled pacers, and can […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
How AI can detect cervical cancer
Researchers have developed a computer algorithm that they say can analyze digital images of a woman’s cervix and accurately identify precancerous changes that require medical attention. This artificial intelligence approach, called automated visual evaluation, has the potential to revolutionize cervical cancer screening, particularly in low-resource settings. Led by investigators from the National Institutes of Health […]
Experts explore the state of M&A in medtech
At DeviceTalks West 2018, a panel of experts gathered to discuss the state of M&A in medtech and the forces driving startups to seek an exit. Buyouts like Medtronic‘s (NYSE:MDT) $1.7 billion acquisition of Mazor Robotics (NSDQ:MZOR) dominated the headlines in 2018, but industry veteran Shayan Bhattacharyya found himself intrigued by the smaller deals that didn’t […]
Olympus inks precision cancer imaging and treatment dev deal with USC
Olympus (TYO:7733) said late last week that it inked a co-development partnership with the University of Southern California looking to advance multiscale research into cancer prevention, diagnosis and treatment through the use of precision medicine. The deal is a first for the university and the company, Olympus said, adding that it hopes that the personalized treatments […]
What’s ahead for the drug delivery market in 2019?
Cindy Reiss-Clark, VP & GM of West‘s (NYSE:WST) global biologics business, comments on the drug delivery trends that stood out from 2018 and what she’s keeping an eye on in the coming year. What were the trends that drove the biopharma and drug delivery markets in 2018? Many of 2018’s key trends revolved around increasing regulatory […]
Edwards Lifesciences pays $180m to bury the hatchet with Boston Scientific
Boston Scientific (NYSE:BSX) and Edwards Lifesciences (NYSE:EW) said today that they’re burying the hatchet, settling their worldwide patent war over cardiac valve and implant technology, with Edwards paying $180 million to end the dispute. “All pending cases or appeals in courts and patent offices between the two companies will be dismissed, and the parties will not litigate […]
5 top stories that mattered for medtech in 2018
The medical device industry faced some major challenges over the past year, from increased media scrutiny to regulatory uncertainty in both the U.S. and E.U. It’s worth noting, though, that many things have been going right for medtech. More than half of the roughly 100 largest medical device companies in the world saw their stock […]
InspireMD inks distro deal for CGuard in South Africa
InspireMD (NYSE:NSPR) said today that it inked a deal with Torque Medical to distribute its CGuard Embolic Prevention System in South Africa. The Israel-based company reported that it will begin the commercial launch for CGuard in South Africa immediately. “We are extremely pleased with the opportunity to offer CGuard EPS in the South African market. We […]
Pharma stocks fall as Rep. Cummings launches drug pricing investigation
Chairman of the House Oversight Committee Rep. Elijah Cummings (D-MD) launched an investigation today into the drug pricing practices of 12 pharmaceutical companies. A number of companies named in the investigation saw their stock prices fall, including Amgen (NSDQ:AMGN), AbbVie (NYSE:ABBV), AstraZeneca (NYSE:AZN), Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO). A hearing is reportedly set for Jan. 29 and will include patients affected by rising […]
Presbia reaches ISO medical device quality milestone
Presbia (Nasdaq:LENS) said today that it has successfully completed the ISO 13485:2016 audit with no major findings. Officials at the Dublin, Ireland–based ophthalmic device company described the audit completion as an essential step toward recertifying under the ISO standard. The company – which has administrative offices and manufacturing in Irvine, Calif. – will receive annual surveillance […]
Trice Medical adds $18m extension to Series C round
Trice Medical said today that it added more than $18 million to the $19 million Series C round it closed back in 2017. Malvern, Pa.-based Trice, which makes the Mi-eye 2 and Mi-ultra orthopedic diagnostic devices, first closed its $19.3 million C round in June 2017. That tranche was led by Smith & Nephew (NYSE:SNN) and included Safeguard Scientifics (NYSE:SFE), […]